Ishares Core S&P 500 ETF (IVV)
$315.72 1.61 (0.51%)
17:09 EDT IVV Stock Quote Delayed 30 Minutes
Previous Close $317.33
Market Cap 174.44B
PE Ratio -
Volume (Avg. Vol.) 3.29M
Day's Range 311.89 - 318.33
52-Week Range 220.28 - 340.63
Dividend & Yield 5.06 (1.60%)
IVV Stock Predictions, Articles, and Ishares Core S&P 500 ETF News
- From InvestorPlace
- From the Web
The 10 best index funds are a mix of buy-and-hold ETFs that will serve you for decades, as well as a couple tactical trading tools.
Launched all the way back on March 4, 1957, the S&P 500’s largest company by market capitalization [share price multiplied by number of shares outstanding] is Apple (NASDAQ:AAPL) at $1.07 trillion, the smallest is Quanta Services (NYSE:PWR) at $5.07 billion, and the median stock is $22.07 billion.
Low-cost ETFs make for great mutual fund substitutes. Here are three great ETFs to buy instead of their actively managed cousins.
Facebook CEO Mark Zuckerberg went to Harvard before dropping out in 2005, so that he could run his social media company on a full-time basis. Now he’s worth $69.0 billion or 50% more than Harvard’s entire endowment.
There is a variety of leveraged ETFs tracking the S&P 500, but there are important differences to consider when finding the best ETFs for you.
With momentum going into Q4 2018, investors who don't mind the potential for price volatility may find energy ETF XLE attractive.
The active vs passive investing debate is not an either/or argument. Investors can gain advantages from each, depending on where they invest.
Large-cap ETFs are attracting attention as investor fears regarding market performance recede. Compare Brokers...
FAAMG accounted for more than half of the gains in the S&P 500 index in October.
The iShares Core S&P 500 ETF (IVV) charges minuscule fees for basic, broad market tracking. Is IVV right for you?
These cheap index funds offer comprehensive access to U.S. stocks, global equities, bonds and more for just a few bucks a year.
As we speak, $376 billion is locked up in five of Wall Street's most overrated, overloved funds. Here are solid alternative ETF plays
The SPDR S&P 500 ETF's (SPY) is the biggest and one of the most basic ETFs out there. Learn more about the SPY ETF: the granddaddy of 'em all.
Exchange-traded funds like IVW (growth stocks) and IVE (value stocks) let you fine-tune your portfolio to enhance performance.
Real estate investment trusts (REITs) can survive hikes in interest rates, but REIT ETFs like VNQ and IYR will stumble at the very least.
Index funds are still the best building blocks for your portfolio, and these three are great index ETFs that get the job done.
Never mind the abysmal first quarter earnings for the depressed energy sector. It doesn't matter. Price does, and these sector stocks are thriving
PsychedelicNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Regulatory Review
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced that it has been selected for a continuous disclosure review by the British Columbia Securities Commission (the “Commission”). The review relates to Champignon’s disclosure obligations since it became a reporting issuer on […]
PsychedelicNewsBreaks – Champignon Brands Inc.’s (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Dr. McIntyre / CRTCE Published in Two Peer Reviewed Study Journals
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, continues to highlight the scientific merit of its ketamine treatments for Major Depressive Disorder (“MDD”) while demonstrating rapid onset efficacy and safety of its treatment processes. To this accord, the Company today announced that […]
CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Provides Corporate Update
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, on Friday provided a corporate update. Since commencing trading on March 2, 2020, the Company has expanded its initiatives and rapidly executed on such initiatives to position it as a leading publicly traded psychedelic medicine […]